{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:53Z","timestamp":1786118933360,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1097\/01.fpc.0000220565.90466.79","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T06:48:59Z","timestamp":1209883739000},"page":"569-577","source":"Crossref","is-referenced-by-count":27,"title":["Association of V227A PPAR\u03b1 polymorphism with altered serum biochemistry and alcohol drinking in Japanese men"],"prefix":"10.1097","volume":"16","author":[{"given":"Hisao","family":"Naito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yamanoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Kamijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamie","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210214","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2008-1040605","article-title":"Histologic spectrum of alcoholic liver disease","volume":"6","author":"MacSween","year":"1986","journal-title":"Semin Liver Dis"},{"key":"R2-5-20210214","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0741-8329(02)00204-5","article-title":"Liver disease in alcohol abusers: clinical perspective","volume":"27","author":"Diehl","year":"2002","journal-title":"Alcohol"},{"key":"R3-5-20210214","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.alcohol.2004.07.005","article-title":"Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha","volume":"34","author":"Crabb","year":"2004","journal-title":"Alcohol"},{"key":"R4-5-20210214","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/hep.20399","article-title":"Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage","volume":"40","author":"Nakajima","year":"2004","journal-title":"Hepatology"},{"key":"R5-5-20210214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/ajpgi.00056.2004","article-title":"Recent advances in alcoholic liver disease. II Minireview: molecular mechanisms of alcoholic fatty liver","volume":"287","author":"You","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R6-5-20210214","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"R7-5-20210214","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00210629","article-title":"Transcription, adipocyte differentiation, and obesity","volume":"74","author":"Auwerx","year":"1996","journal-title":"J Mol Med"},{"key":"R8-5-20210214","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/me.2004-0088","article-title":"Be fit or be sick: peroxisome proliferator-activated receptors are down the road","volume":"18","author":"Desvergne","year":"2004","journal-title":"Mol Endocrinol"},{"key":"R9-5-20210214","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"61","author":"Mandard","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"R10-5-20210214","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology"},{"key":"R11-5-20210214","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/diab.46.8.1319","article-title":"Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients","volume":"46","author":"Auboeuf","year":"1997","journal-title":"Diabetes"},{"key":"R12-5-20210214","doi-asserted-by":"crossref","first-page":"25573","DOI":"10.1074\/jbc.273.40.25573","article-title":"Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages","volume":"273","author":"Chinetti","year":"1998","journal-title":"J Biol Chem"},{"key":"R13-5-20210214","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1006\/bbrc.1998.8622","article-title":"Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells","volume":"246","author":"Inoue","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R14-5-20210214","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","article-title":"Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators","volume":"393","author":"Staels","year":"1998","journal-title":"Nature"},{"key":"R15-5-20210214","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1073\/pnas.90.6.2160","article-title":"Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers","volume":"90","author":"Keller","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"R16-5-20210214","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","article-title":"Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta","volume":"94","author":"Forman","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R17-5-20210214","doi-asserted-by":"crossref","first-page":"23975","DOI":"10.1074\/jbc.270.41.23975","article-title":"Differential activation of peroxisome proliferator-activated receptors by eicosanoids","volume":"270","author":"Yu","year":"1995","journal-title":"J Biol Chem"},{"key":"R18-5-20210214","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/384039a0","article-title":"The PPARalpha-leukotriene B4 pathway to inflammation control","volume":"384","author":"Devchand","year":"1996","journal-title":"Nature"},{"key":"R19-5-20210214","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.1996.tb18616.x","article-title":"Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon","volume":"804","author":"Reddy","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"R20-5-20210214","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1749-6632.1996.tb18620.x","article-title":"Peroxisome proliferator-activated receptors: structures and function","volume":"804","author":"Tugwood","year":"1996","journal-title":"Ann NY Acad Sci"},{"key":"R21-5-20210214","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0076-6879(94)33061-1","article-title":"Animal models of chronic ethanol toxicity","volume":"233","author":"Lieber","year":"1994","journal-title":"Methods Enzymol"},{"key":"R22-5-20210214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0220001","article-title":"Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences","volume":"22","author":"Holden","year":"1999","journal-title":"J Mol Endocrinol"},{"key":"R23-5-20210214","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00008571-200006000-00006","article-title":"The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants","volume":"10","author":"Sapone","year":"2000","journal-title":"Pharmacogenetics"},{"key":"R24-5-20210214","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s001250051357","article-title":"Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects","volume":"43","author":"Flavell","year":"2000","journal-title":"Diabetologia"},{"key":"R25-5-20210214","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-2275(20)32037-X","article-title":"Molecular scanning of the human PPARa gene: association of the L162V mutation with hyperapobetalipoproteinemia","volume":"41","author":"Vohl","year":"2000","journal-title":"J Lipid Res"},{"key":"R26-5-20210214","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.ATV.0000012302.11991.42","article-title":"Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study","volume":"22","author":"Tai","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R27-5-20210214","first-page":"393","article-title":"Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease","volume":"26","author":"Lacquemant","year":"2000","journal-title":"Diabetes Metab"},{"key":"R28-5-20210214","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jmg.39.3.189","article-title":"A Val227Ala polymorphism in the peroxisome proliferator activated receptor alpha (PPARalpha) gene is associated with variations in serum lipid levels","volume":"39","author":"Yamakawa-Kobayashi","year":"2002","journal-title":"J Med Genet"},{"key":"R30-5-20210214","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/00004872-199715110-00004","article-title":"Effects of daily alcohol intake on the blood pressure differ depending on an individual's sensitivity to alcohol: oriental flushing as a sign to stop drinking for health reasons","volume":"15","author":"Itoh","year":"1997","journal-title":"J Hypertens"},{"key":"R31-5-20210214","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0014-5793(00)01710-5","article-title":"Aldehyde dehydrogenase (ALDH) 2 associates with oxidation of methoxyacetaldehyde: in vitro analysis with liver subcellular fraction derived from human and Aldh2 gene targeting mouse","volume":"476","author":"Kitagawa","year":"2000","journal-title":"FEBS Lett"},{"key":"R32-5-20210214","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0741-8329(85)90024-2","article-title":"Molecular abnormality and cDNA cloning of human aldehyde dehydrogenases","volume":"2","author":"Yoshida","year":"1985","journal-title":"Alcohol"},{"key":"R33-5-20210214","first-page":"693","article-title":"Genetic polymorphisms of alcohol metabolizing enzymes related to alcohol sensitivity and alcoholic diseases","volume":"29","author":"Yoshida","year":"1994","journal-title":"Alcohol"},{"key":"R34-5-20210214","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.94.13.6820","article-title":"Exon\/intron structure of aldehyde dehydrogenase genes supports the \u2018introns-late\u2019 theory","volume":"94","author":"Rzhetsky","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R35-5-20210214","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000028400","article-title":"Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease","volume":"61","author":"Vasiliou","year":"2000","journal-title":"Pharmacology"},{"key":"R36-5-20210214","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1074\/jbc.M008791200","article-title":"The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver","volume":"276","author":"Galli","year":"2001","journal-title":"J Biol Chem"},{"key":"R37-5-20210214","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/bit.20073","article-title":"Single nucleotide polymorphism detection in aldehyde dehydrogenase 2 (ALDH2) gene using bacterial magnetic particles based on dissociation curve analysis","volume":"87","author":"Maruyama","year":"2004","journal-title":"Biotechnol Bioeng"},{"key":"R38-5-20210214","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s100380170080","article-title":"Identification of three missense mutations in the peroxisome proliferator-activated receptor alpha gene in Japanese subjects with maturity-onset diabetes of the young","volume":"46","author":"Hara","year":"2001","journal-title":"J Hum Genet"},{"key":"R39-5-20210214","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00008571-200307000-00007","article-title":"Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjects","volume":"13","author":"Nielsen","year":"2003","journal-title":"Pharmacogenetics"},{"key":"R40-5-20210214","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ajmg.1620","article-title":"Mutation analysis of the retinoid X receptor, beta nuclear-related receptor 1, and peroxisome proliferator-activated receptor alpha genes in schizophrenia and alcohol dependence: possible haplotype association of nuclear-related receptor 1 gene to alcohol dependence","volume":"114","author":"Ishiguro","year":"2002","journal-title":"Am J Med Genet"},{"key":"R41-5-20210214","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0278-6915(02)00049-2","article-title":"Molecular modelling of the peroxisome proliferator-activated receptor alpha (PPAR alpha) from human, rat, and mouse, based on homology with the human PPAR gamma crystal structure","volume":"16","author":"Lewis","year":"2002","journal-title":"Toxicol In Vitro"},{"key":"R42-5-20210214","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1074\/jbc.272.43.27307","article-title":"Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice","volume":"272","author":"Peters","year":"1997","journal-title":"J Biol Chem"},{"key":"R43-5-20210214","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1074\/jbc.270.22.13470","article-title":"Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppressi on of apolipoprotein C-III","volume":"270","author":"Hertz","year":"1995","journal-title":"J Biol Chem"},{"key":"R44-5-20210214","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00041433-200106000-00009","article-title":"Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism","volume":"12","author":"Shachter","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"R45-5-20210214","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1042\/bj20031565","article-title":"Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level","volume":"378","author":"Lee","year":"2004","journal-title":"Biochem J"},{"key":"R46-5-20210214","doi-asserted-by":"crossref","first-page":"27997","DOI":"10.1074\/jbc.M302140200","article-title":"Peroxisome proliferator-activated receptor alpha (PPARalpha) agonist treatment reverses PPARalpha dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice","volume":"278","author":"Fischer","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.fpc.0000220565.90466.79","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:04:57Z","timestamp":1786035897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-200608000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fpc.0000220565.90466.79","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}